⚖ Compare news

Put up to three stories side by side. Pick IDs from any article URL: /compare?id=123&id=456

From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments

channelnewsasia.com ·Singapore · tech
Words
22
Chars
170
AI summary
Yes
Full story

Biomedical startups from Singapore are expanding their operations into China. These companies aim to accelerate the development of treatments for conditions such as cancer and diabetes. They are utilizing China's large patient population and hospital networks. The startups are also using Chinese manufacturing capabilities. However, they must manage changing regulations in the country.

Singapore startups are tapping China’s vast patient pool, hospital networks and manufacturing capabilities, but they must also navigate its evolving regulatory landscape.

Open article